This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Colorado. Active years: 2014-2018.
Location History:
- Denver, CO (US) (2014)
- Lakewood, CO (US) (2018)
Company Filing History:
Years Active: 2014-2018
Title: Beth Tamburini: Innovator in Yeast-Based Immunotherapy
Introduction
Beth Tamburini is a prominent inventor based in Lakewood, Colorado. She has made significant contributions to the field of immunotherapy, particularly through her innovative work with yeast-based products. With a total of two patents to her name, her research focuses on enhancing immune responses through novel methodologies.
Latest Patents
Beth's latest patents include groundbreaking methods for the modulation of yeast-based immunotherapy products and the immune responses they elicit. These patents disclose techniques to improve prophylactic and therapeutic responses, as well as the development of modified yeast-based immunotherapy products, kits, and compositions. Her work is pivotal in advancing the efficacy of immunotherapy treatments.
Career Highlights
Beth Tamburini is affiliated with the University of Colorado, where she continues to push the boundaries of research in immunotherapy. Her dedication to innovation has positioned her as a key figure in her field, contributing to both academic and practical advancements in healthcare.
Collaborations
Beth collaborates with Donald Bellgrau, a fellow researcher, to further explore the potential of yeast-based immunotherapy. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Beth Tamburini's work in yeast-based immunotherapy represents a significant advancement in the field, showcasing her commitment to improving health outcomes through innovative research. Her contributions are expected to have a lasting impact on immunotherapy practices.